-
Loading metrics
Open Access
Peer-reviewed
Research Article
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
-
Sara Llufriu ,
Contributed equally to this work with: Sara Llufriu, María Sepúlveda
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
María Sepúlveda ,
Contributed equally to this work with: Sara Llufriu, María Sepúlveda
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Yolanda Blanco,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Pedro Marín,
Affiliation Hemotherapy Service, CDB, Hospital Clínic, Barcelona, Spain
⨯ -
Beatriz Moreno,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Joan Berenguer,
Affiliation Service of Neurorradiology, Hospital Clinic and Institut d′Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Iñigo Gabilondo,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Eloy Martínez-Heras,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Nuria Sola-Valls,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Joan-Albert Arnaiz,
Affiliation Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain
⨯ -
Enrique J. Andreu,
Affiliation Cell Therapy Area, Clinica Universitaria de Navarra, Pamplona, Spain
⨯ -
Begoña Fernández,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Santi Bullich,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Bernardo Sánchez-Dalmau,
Affiliations Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain, Service of Ophtalmology, Hospital Clinic, Barcelona, Spain
⨯ -
Francesc Graus,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ -
Pablo Villoslada,
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ - [ ... ],
-
Albert Saiz
* E-mail: asaiz@clinic.ub.es
Affiliation Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⨯ - [ view all ]
- [ view less ]
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
- Sara Llufriu,
- María Sepúlveda,
- Yolanda Blanco,
- Pedro Marín,
- Beatriz Moreno,
- Joan Berenguer,
- Iñigo Gabilondo,
- Eloy Martínez-Heras,
- Nuria Sola-Valls,
- Joan-Albert Arnaiz
- Published: December 1, 2014
- https://doi.org/10.1371/journal.pone.0113936